Xeris Biopharma: Q4 Earnings Snapshot

CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Wednesday reported a loss of $12.9 million in its fourth quarter.

On a per-share basis, the Chicago-based company said it had a loss of 10 cents.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.

The company posted revenue of $33.1 million in the period, also topping Street forecasts. Four analysts surveyed by Zacks expected $31 million.

For the year, the company reported a loss of $94.7 million, or 70 cents per share. Revenue was reported as $110.2 million.

Xeris Biopharma expects full-year revenue in the range of $135 million to $165 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XERS at https://www.zacks.com/ap/XERS

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up